November 17, 2026 · Radiology · DOI: 10.1148/radiol.261687

Histotripsy versus Established Thermal Ablation Technologies: A Comparative Analysis of FDA MAUDE Adverse Event Reporting Patterns.

Listen to this summary

This study compared adverse event reports in the FDA MAUDE database for histotripsy, a newly cleared liver tumor ablation technology, against pooled microwave and radiofrequency ablation reports over comparable early postmarket periods. The authors asked whether histotripsy shows a higher reported frequency of serious injury and death. They found histotripsy had substantially higher reporting odds of serious injury and death than pooled MWA/RFA, though the authors caution that differences in technology maturity and reporting era may explain part of this gap and that prospective study is needed.

Ashima Kundu, Alda Tam, Lili Zhao, Robert J Lewandowski, Andrew C Gordon

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play